{"id":"W4379645897","doi":"10.1200/jco.2023.41.17_suppl.lba8505","title":"IND227 phase III (P3) study of cisplatin/pemetrexed (CP) with or without pembrolizumab (pembro) in patients (pts) with malignant pleural mesothelioma (PM): A CCTG, NCIN, and IFCT trial.","year":2023,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Occupational and environmental lung diseases","field":"Medicine","cited_by":32,"is_retracted":false,"has_abstract":true,"ca_institutions":"Surrey Memorial Hospital; University of Ottawa; CancerCare Manitoba; Ottawa Hospital; Princess Margaret Cancer Centre; Queen's University; University Health Network; Centre Hospitalier de l’Université de Montréal","funders":"","keywords":"Medicine; Pemetrexed; Carboplatin; Pembrolizumab; Internal medicine; Lung cancer; Oncology; Tolerability; Progression-free survival; Neutropenia; Cancer; Chemotherapy; Cisplatin; Adverse effect; Immunotherapy","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001194794,0.001298375,0.001414363,0.0003411937,0.0005085929,0.001153672,0.001011558,0.001389371,0.005249344],"category_scores_gemma":[0.0007072887,0.0004291277,0.001408323,0.0005385001,0.0006308808,0.0004976271,0.0003638546,0.003151937,0.001277656],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.002216275,"about_ca_system_score_gemma":0.003099106,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.01247428,"about_ca_topic_score_gemma":0.03360115,"domain_scores_codex":[0.9996377,0.0001694684,0.000009656767,0.0000483288,0.0000500158,0.00008472696],"domain_scores_gemma":[0.9995981,0.00004221824,0.00009548113,0.00002328939,0.00003430388,0.0002066884],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.8162942,0.02068293,0.004923473,0.002155907,0.002397265,0.0003228256,0.0002124134,0.002198711,0.01849624,0.0006325503,0.03528282,0.09640066],"study_design_scores_gemma":[0.8974081,0.07812595,0.01168097,0.0001221928,0.0007998918,0.0003021382,0.00005178545,0.0009688055,0.001327831,0.0002765743,0.008905567,0.00003024949],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.945225,0.01308592,0.0009804746,0.00347682,0.0006747693,0.008733034,0.01377233,0.0004046121,0.01364707],"genre_scores_gemma":[0.9551581,0.004975246,0.002606911,0.004699034,0.000343279,0.006921735,0.01434629,0.0001161793,0.01083322],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.01247428,"threshold_uncertainty_score":0.02480334,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.105704442441887,"score_gpt":0.4540090366309261,"score_spread":0.348304594189039,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}